We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » The 510(k) Process - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - Nov. 14, 2018

$287.00

Audio Recording/Transcript - Nov. 14, 2018

$258.00

Audio Recording/Transcript - Nov. 14, 2018

$244.00

Audio Recording/Transcript - Nov. 14, 2018

$230.00

Audio Recording/Transcript - Nov. 14, 2018

$215.00

The 510(k) Process - Webinar Recording/Transcript

$287.00
Webinar Recordings

Product Details

The 510(k) Process: A Whirlwind of Change, Challenges, and Opportunities

As medical device software and other technology continue to advance at a rapid pace, the FDA’s regulatory policies and processes are being forced to evolve to keep pace with innovation.

FDAnews has enlisted attorneys Jennifer Nowark and Sara Klock of Holland and Knight to guide you through the whirlwind of regulatory change.  They’ll discuss the recent guidance (Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics) and to what extent technology will be regulated by the FDA. Over the course of 90 minutes, they’ll provide insight into what will be regulated as medical device technology and what may cause the technology to require premarket review.

You’ll learn about:

  • The agency’s groundbreaking pilot program that determines whether the clearance process can and should be updated
  • How the FDA’s recent final guidance affects regulatory specialists
  • How to identify factors that determine the extent certain new technologies are regulated as medical devices
  • How the FDA’s Expanded Abbreviated 510(k) program affects you
  • What characteristics may cause your technology to require premarket review
  • How the FDA is addressing potential vulnerabilities, such as cybersecurity risks

Order today to learn about the recent trends and initiatives affecting the 510(k) process as well as the evolving regulatory framework that may result in changes to the types of devices subject to 510(k) clearance.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing